A Study to Assess the Efficacy and Safety of ASP1941 in Asian Subjects With Type 2 Diabetes Mellitus

PHASE3TerminatedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

April 23, 2012

Primary Completion Date

October 19, 2012

Study Completion Date

October 19, 2012

Conditions
Type II Diabetes Mellitus
Interventions
DRUG

ASP1941

oral

DRUG

acarbose

oral

DRUG

Placebo

oral, used only during placebo run-in period

Trial Locations (15)

Unknown

Busan

Daegu

Daejeon

Gwangju

Incheon

Seongnam

Seoul

Wŏnju

Changha

Chiayi City

Kaohsiung City

Taichung

Tainan City

Taipei

Taoyuan District

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY

NCT01514838 - A Study to Assess the Efficacy and Safety of ASP1941 in Asian Subjects With Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter